Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/628 |
Resumo: | Introduction: Studies suggest that, in addition to the systemic effects, chemotherapy can lead to cognitive alterations in patients. These changes have had increasing attention due to the repercussion that these effects cause in patients who survive a cancer treatment. Objective: To study the domains of cognitive function impaired in patients who underwent chemotherapy, by means of a systematic review of the evaluation methods used to identify the presence of these alterations and their possible mechanisms of occurrence. Method: A systematic review was conducted from a bibliographic survey of articles from the last 10 years, in the Lilacs, Medline and Pubmed database. the key words were randomly combined in Portuguese: “quimioterapia”, “cognicao”, “neurotoxicidade”, “antineoplasicos”, “cancer”, and in English "chemobrain", "Neurocognitive function", "chemofog." Results: The cognitive function presented itself impaired after chemotherapy was carried out. A large array of evaluation methods of the cognitive function was found, highlighting the lack of standardization. The possible mechanisms for which chemotheraphy provokes impairment are related to the capacity of crossing the blood-brain barrier; DNA damage, regulation of cytokines, neural repair, genetic alteration of neurotransmitters, and changes in the levels of estrogen and testosterone hormones. Conclusion: The following cognitive domains: verbal memory, working memory, executive function, attention, concentration, language and motor speed are the most affected in patients undergoing chemotherapy. |
id |
INCA-1_4c7a61f06ba296ce1cc8a6566fbf7b2c |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/628 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic ReviewLa Función Cognitiva en Pacientes Sometidos a la Quimioterapia: una Revisión IntegradoraA Função Cognitiva em Pacientes Submetidos à Quimioterapia: uma Revisão IntegrativaNeoplasias/quimioterapiaQuimioterapia/efeitos adversosQuimioterapia/psicologiaCogniçãoRevisãoNeoplasms/drug therapyDrug Therapy/adverse effectsDrug Therapy/psychologyCognitionReviewNeoplasias/quimioterapiaQuimioterapia/efectos adversosQuimioterapia/psicologíaCogniciónRevisiónIntroduction: Studies suggest that, in addition to the systemic effects, chemotherapy can lead to cognitive alterations in patients. These changes have had increasing attention due to the repercussion that these effects cause in patients who survive a cancer treatment. Objective: To study the domains of cognitive function impaired in patients who underwent chemotherapy, by means of a systematic review of the evaluation methods used to identify the presence of these alterations and their possible mechanisms of occurrence. Method: A systematic review was conducted from a bibliographic survey of articles from the last 10 years, in the Lilacs, Medline and Pubmed database. the key words were randomly combined in Portuguese: “quimioterapia”, “cognicao”, “neurotoxicidade”, “antineoplasicos”, “cancer”, and in English "chemobrain", "Neurocognitive function", "chemofog." Results: The cognitive function presented itself impaired after chemotherapy was carried out. A large array of evaluation methods of the cognitive function was found, highlighting the lack of standardization. The possible mechanisms for which chemotheraphy provokes impairment are related to the capacity of crossing the blood-brain barrier; DNA damage, regulation of cytokines, neural repair, genetic alteration of neurotransmitters, and changes in the levels of estrogen and testosterone hormones. Conclusion: The following cognitive domains: verbal memory, working memory, executive function, attention, concentration, language and motor speed are the most affected in patients undergoing chemotherapy. Introducción: Estudios sugieren que, además de los efectos sistémicos, la quimioterapia puede llevar a alteraciones cognitivas en los pacientes. Estas alteraciones reciben creciente atención debido a la repercusión que eses efectos causan en la vida de aquellos que supervivieran a un tratamiento para el cáncer. Objetivo: Estudiar la función cognitiva em pacientes sometidos la quimioterapia. Método: Se realizó una revisión integradora desde una revision bibliográfica de artículos de los últimos 10 años, la base de datos Lilacs, Medline y PubMed. Se combinan de forma aleatoria las palabras clave en portugués "quimioterapia", "cognición", "neurotoxicidad", "antineoplásico", "cáncer", e Inglés "chemobrain", "neurocognitive function", "chemofog". Resultados: La función cognitiva se presentó perjudicada después de la realización de la quimioterapia en diversos ámbitos. Una diversidad de métodos de evaluación de la función cognitiva fue encontrada evidenciando una falla de patrón. Los posibles mecanismos por los cuales la quimioterapia favorece el perjuicio cognitivo están relacionados a la capacidad de atravesar la barrera hematoencefálica, daños al DNA, regulación de las citocinas, reparación neural, alteración genética de neurotransmisores y alteración en los niveles de hormonas estrógeno y testosterona. Conclusión: Los dominios cognitivos memoria verbal, memoria de trabajo, función ejecutiva, atención, concentración, lenguaje y velocidad motora son los más perjudicados en pacientes sometidos a la quimioterapia.Introdução: Estudos sugerem que, além dos efeitos sistêmicos, a quimioterapia pode levar a alterações cognitivas nos pacientes. Essas alterações tem recebido crescente atenção devido à repercussão que esses efeitos causam na vida daqueles que sobreviveram após um tratamento para o câncer. Objetivo: Estudar os domínios da função cognitiva prejudicados em pacientes submetidos a quimioterapia, através de uma revisão integrativa sobre os métodos de avaliação utilizados para determinar a presença dessas alterações e os seus possíveis mecanismos de ocorrência. Método: Realizou-se uma revisão integrativa a partir de levantamento bibliográfico de artigos dos últimos dez anos, na base de dados Lilacs, Medline e Pubmed. Foram combinadas aleatoriamente as palavras-chave em português: “quimioterapia”, “cognição”, “neurotoxicidade”, “antineoplásicos”, “câncer”; e em inglês: “chemobrain”, “neurocognitive function”,”chemofog”. Resultados: A função cognitiva apresenta-se prejudicada após a realização da quimioterapia em diversos domínios. Uma vasta gama de métodos de avaliação da função cognitiva foi encontrada, evidenciando uma ausência de padronização. Os possíveis mecanismos pelos quais a quimioterapia provoca prejuízo cognitivo estão relacionados a capacidade de atravessar a barreira hematocefálica; danos ao DNA; regulação das citocinas; reparo neural; alteração genética de neurotransmissores; e alteração nos níveis de hormônios estrógeno e testosterona. Conclusão: Os domínios cognitivos memória verbal, memória de trabalho, função executiva, atenção, concentração, linguagem e velocidade motora são os mais prejudicados em pacientes submetidos à quimioterapia. INCA2012-06-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisão de literaturaapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/62810.32635/2176-9745.RBC.2012v58n2.628Revista Brasileira de Cancerologia; Vol. 58 No. 2 (2012): Apr./May/June; 257-265Revista Brasileira de Cancerologia; Vol. 58 Núm. 2 (2012): abr./mayo/jun.; 257-265Revista Brasileira de Cancerologia; v. 58 n. 2 (2012): abr./maio/jun. ; 257-2652176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/628/396Untura, Lindsay Pâmela Rezende, Laura Ferreira de info:eu-repo/semantics/openAccess2021-11-29T20:14:26Zoai:rbc.inca.gov.br:article/628Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:14:26Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review La Función Cognitiva en Pacientes Sometidos a la Quimioterapia: una Revisión Integradora A Função Cognitiva em Pacientes Submetidos à Quimioterapia: uma Revisão Integrativa |
title |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review |
spellingShingle |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review Untura, Lindsay Pâmela Neoplasias/quimioterapia Quimioterapia/efeitos adversos Quimioterapia/psicologia Cognição Revisão Neoplasms/drug therapy Drug Therapy/adverse effects Drug Therapy/psychology Cognition Review Neoplasias/quimioterapia Quimioterapia/efectos adversos Quimioterapia/psicología Cognición Revisión |
title_short |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review |
title_full |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review |
title_fullStr |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review |
title_full_unstemmed |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review |
title_sort |
Cognitive Function in Patients Undergoing Chemotherapy: a Systematic Review |
author |
Untura, Lindsay Pâmela |
author_facet |
Untura, Lindsay Pâmela Rezende, Laura Ferreira de |
author_role |
author |
author2 |
Rezende, Laura Ferreira de |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Untura, Lindsay Pâmela Rezende, Laura Ferreira de |
dc.subject.por.fl_str_mv |
Neoplasias/quimioterapia Quimioterapia/efeitos adversos Quimioterapia/psicologia Cognição Revisão Neoplasms/drug therapy Drug Therapy/adverse effects Drug Therapy/psychology Cognition Review Neoplasias/quimioterapia Quimioterapia/efectos adversos Quimioterapia/psicología Cognición Revisión |
topic |
Neoplasias/quimioterapia Quimioterapia/efeitos adversos Quimioterapia/psicologia Cognição Revisão Neoplasms/drug therapy Drug Therapy/adverse effects Drug Therapy/psychology Cognition Review Neoplasias/quimioterapia Quimioterapia/efectos adversos Quimioterapia/psicología Cognición Revisión |
description |
Introduction: Studies suggest that, in addition to the systemic effects, chemotherapy can lead to cognitive alterations in patients. These changes have had increasing attention due to the repercussion that these effects cause in patients who survive a cancer treatment. Objective: To study the domains of cognitive function impaired in patients who underwent chemotherapy, by means of a systematic review of the evaluation methods used to identify the presence of these alterations and their possible mechanisms of occurrence. Method: A systematic review was conducted from a bibliographic survey of articles from the last 10 years, in the Lilacs, Medline and Pubmed database. the key words were randomly combined in Portuguese: “quimioterapia”, “cognicao”, “neurotoxicidade”, “antineoplasicos”, “cancer”, and in English "chemobrain", "Neurocognitive function", "chemofog." Results: The cognitive function presented itself impaired after chemotherapy was carried out. A large array of evaluation methods of the cognitive function was found, highlighting the lack of standardization. The possible mechanisms for which chemotheraphy provokes impairment are related to the capacity of crossing the blood-brain barrier; DNA damage, regulation of cytokines, neural repair, genetic alteration of neurotransmitters, and changes in the levels of estrogen and testosterone hormones. Conclusion: The following cognitive domains: verbal memory, working memory, executive function, attention, concentration, language and motor speed are the most affected in patients undergoing chemotherapy. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-06-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Revisão de literatura |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/628 10.32635/2176-9745.RBC.2012v58n2.628 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/628 |
identifier_str_mv |
10.32635/2176-9745.RBC.2012v58n2.628 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/628/396 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 58 No. 2 (2012): Apr./May/June; 257-265 Revista Brasileira de Cancerologia; Vol. 58 Núm. 2 (2012): abr./mayo/jun.; 257-265 Revista Brasileira de Cancerologia; v. 58 n. 2 (2012): abr./maio/jun. ; 257-265 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042244699553792 |